Symptom Presentation Outcomes, 2020-2024
Cumberland Heights patient outcomes data shows meaningful symptom improvement alongside increased recovery capital, suggesting treatment supports both clinical stabilization and long-term recovery readiness.
- Depression symptoms decreased by an average of 64.2%.
- Anxiety symptoms decreased by an average of 60.2%.
Longer Treatment Engagement Is Linked to Lower Readmission
Patients who stayed engaged in treatment for at least 30 days had lower readmission rates at each post-discharge checkpoint shown, reinforcing the value of sustained care beyond the earliest stage of treatment.
- At 90 days, readmission was 8% for patients with at least 30 days in treatment compared with 15% for those with less than 30 days.
- At 180 days, readmission was 10% compared with 17%.
Depression Symptoms Decline During and After Treatment
Across recent patient cohorts, average depression scores declined during treatment and remained lower through post-discharge follow-up, pointing to improvement that extends beyond the residential treatment window.
- Average depression scores dropped steadily from admission through week four of treatment.
- Lower symptom scores were sustained at one, six and twelve months after discharge.
Anxiety Symptoms Decline During and After Treatment
The anxiety outcomes chart shows patients reporting lower anxiety scores as treatment progresses, with improvements generally holding through the first-year post-discharge checkpoints.
- Average anxiety scores declined from admission through discharge.
- Post-discharge follow-up showed anxiety scores remaining below admission levels.
Recovery Capital Builds During and After Treatment
Recovery capital scores increased during treatment and continued to trend upward after discharge, suggesting patients gained practical, relational and personal resources that can support ongoing recovery.
- Average recovery capital scores rose from admission through discharge.
- Scores continued to improve at post-discharge follow-up points.
Treatment Outcomes Improve Key Recovery Measures
This outcomes summary highlights broad improvement across symptom and recovery measures, showing reductions in depression, anxiety and craving symptoms alongside increased recovery capital.
- Depression symptoms decreased by an average of 64.2%.
- Anxiety symptoms decreased by an average of 60.2%.
Research slide 1
Symptom Presentation Outcomes, 2020-2024
Image description: Infographic showing Cumberland Heights patient outcomes from 2020 to 2024, including decreases in depression, anxiety and craving symptoms and an increase in recovery capital.
Summary
Cumberland Heights patient outcomes data shows meaningful symptom improvement alongside increased recovery capital, suggesting treatment supports both clinical stabilization and long-term recovery readiness.
Key findings
- Depression symptoms decreased by an average of 64.2%.
- Anxiety symptoms decreased by an average of 60.2%.
- Craving symptoms decreased by an average of 63.8%.
- Recovery capital increased by an average of 13.2%.
Cumberland Heights Research Institute patient outcomes data, 2020-2024.
Research slide 2
Longer Treatment Engagement Is Linked to Lower Readmission
Image description: Bar chart showing lower post-discharge readmission rates among Cumberland Heights patients who engaged in at least 30 days of treatment.
Summary
Patients who stayed engaged in treatment for at least 30 days had lower readmission rates at each post-discharge checkpoint shown, reinforcing the value of sustained care beyond the earliest stage of treatment.
Key findings
- At 90 days, readmission was 8% for patients with at least 30 days in treatment compared with 15% for those with less than 30 days.
- At 180 days, readmission was 10% compared with 17%.
- At 365 days, readmission was 12% compared with 18%.
Research slide 3
Depression Symptoms Decline During and After Treatment
Image description: Line graph showing average depression symptom scores declining during treatment and remaining lower through the first year after discharge.
Summary
Across recent patient cohorts, average depression scores declined during treatment and remained lower through post-discharge follow-up, pointing to improvement that extends beyond the residential treatment window.
Key findings
- Average depression scores dropped steadily from admission through week four of treatment.
- Lower symptom scores were sustained at one, six and twelve months after discharge.
- The pattern appears consistently across patient cohorts from 2020 through 2024.
Cumberland Heights Research Institute patient outcomes data, 2020-2024.
Research slide 4
Anxiety Symptoms Decline During and After Treatment
Image description: Line graph showing average anxiety symptom scores decreasing during treatment and staying lower at post-discharge follow-up points.
Summary
The anxiety outcomes chart shows patients reporting lower anxiety scores as treatment progresses, with improvements generally holding through the first-year post-discharge checkpoints.
Key findings
- Average anxiety scores declined from admission through discharge.
- Post-discharge follow-up showed anxiety scores remaining below admission levels.
- The trend was visible across multiple annual patient cohorts.
Cumberland Heights Research Institute patient outcomes data, 2020-2024.
Research slide 5
Recovery Capital Builds During and After Treatment
Image description: Line graph showing average recovery capital scores increasing during treatment and continuing to improve after discharge.
Summary
Recovery capital scores increased during treatment and continued to trend upward after discharge, suggesting patients gained practical, relational and personal resources that can support ongoing recovery.
Key findings
- Average recovery capital scores rose from admission through discharge.
- Scores continued to improve at post-discharge follow-up points.
- The trend supports the role of treatment in building recovery resources, not only reducing symptoms.
Cumberland Heights Research Institute patient outcomes data, 2020-2024.
Research slide 6
Treatment Outcomes Improve Key Recovery Measures
Image description: Infographic summarizing Cumberland Heights outcomes from 2020 to 2024, including lower depression, anxiety and craving symptoms and higher recovery capital.
Summary
This outcomes summary highlights broad improvement across symptom and recovery measures, showing reductions in depression, anxiety and craving symptoms alongside increased recovery capital.
Key findings
- Depression symptoms decreased by an average of 64.2%.
- Anxiety symptoms decreased by an average of 60.2%.
- Craving symptoms decreased by an average of 63.8%.
- Recovery capital increased by an average of 13.2%.
Cumberland Heights Research Institute patient outcomes data, 2020-2024.